Evidence map›Paper›PMID 30919138›Full record

ArticleAnnals of biomedical engineering2019

Development of Zinc Chelating Resin Polymer Beads for the Removal of Cell-Free Hemoglobin.

Kelli Simms, Elisabeth Rebholz, Robert M Mayberry, Swati Basu, Andreas Perlegas, Martin Guthold, Daniel B Kim-Shapiro, Elaheh Rahbar

Abstract read
In one paragraph

Article in Annals of biomedical engineering, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kelli SimmsDepartment of Biomedical Engineering, Virginia Tech - Wake Forest School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, 575 N. Patterson Ave., Suite 120, Winston Salem, NC, 27101, USA.
Elisabeth RebholzDepartment of Biomedical Engineering, Virginia Tech - Wake Forest School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, 575 N. Patterson Ave., Suite 120, Winston Salem, NC, 27101, USA.
Robert M MayberryDepartment of Biomedical Engineering, Virginia Tech - Wake Forest School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, 575 N. Patterson Ave., Suite 120, Winston Salem, NC, 27101, USA.
Swati BasuDepartment of Physics, Wake Forest University, 1834 Wake Forest Rd, Winston Salem, NC, 27109, USA.
Andreas PerlegasDepartment of Physics, Wake Forest University, 1834 Wake Forest Rd, Winston Salem, NC, 27109, USA.
Martin GutholdDepartment of Physics, Wake Forest University, 1834 Wake Forest Rd, Winston Salem, NC, 27109, USA.
Daniel B Kim-ShapiroDepartment of Physics, Wake Forest University, 1834 Wake Forest Rd, Winston Salem, NC, 27109, USA.
Elaheh RahbarDepartment of Biomedical Engineering, Virginia Tech - Wake Forest School of Biomedical Engineering and Sciences, Wake Forest School of Medicine, 575 N. Patterson Ave., Suite 120, Winston Salem, NC, 27101, USA. erahbar@wakehealth.edu.

Funding

Resuscitation Outcomes Consortium (ROC) Data Coordinating CenterU01HL077863 · NHLBI · UNIVERSITY OF WASHINGTON · PI MAY, SUSANNE · 2004 to 2015
$125.1M
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Research Desogn and Biostatistics CoreU54MD007588 · NIMHD · MOREHOUSE SCHOOL OF MEDICINE · PI MAYBERRY, ROBERT M · 2012 to 2018
$24.8M
Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide HomeostasisR01HL098032 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mark T Gladwin · 2009 to 2026
$12.5M
Effects of Nitric Oxide in Sickle Cell BloodR01HL058091 · NHLBI · WAKE FOREST UNIVERSITY · PI KIM-SHAPIRO, DANIEL B · 2002 to 2006
$1.6M
National Science Foundation (US) 1559700NCATS NIH HHS UL1 TR002378NHLBI NIH HHS R01 HL058091NHLBI NIH HHS R01 HL098032NHLBI NIH HHS U01 HL077863NIH HHS RO1 HL098032NIH HHS U01 HL077863-11 Subaward No. 0010612B)NIMHD NIH HHS U54 MD007588
6 · The paper itself

Abstract

Red blood cell (RBC) hemolysis is one of the most common storage lesions in packed RBCs (pRBC). Older units of pRBCs, especially those > 21 days old, have increasing levels of hemolysis leading to increased oxidative stress and premature platelet activation. This effect can mostly be attributed to the increase of cell-free hemoglobin (Hb). Therefore, removal of cell-free Hb from pRBCs prior to transfusion could mitigate these deleterious effects. We propose a new method for the removal of Hb from pRBCs using zinc beads. Prepared Hb solutions and pRBCs were treated with zinc beads using two different protocols. UV-Vis spectrophotometry was used to determine Hb concentrations, before and after treatment. Experiments were run in triplicate and paired t tests were used to determine significant differences between groups. Zinc beads removed on average 94% of cell-free Hb within 15 min and 78% Hb from pRBCs (p < 0.0001), demonstrating a maximum binding capacity ~ 66.2 ± 0.7 mg Hb/mL beads. No differences in RBC morphology or deformability were observed after treatment. This study demonstrates the feasibility of using zinc beads for the rapid and targeted removal of Hb from pRBC units. Further investigation is needed to scale this method for large volume removal.

Indexed as

ErythrocytesHemoglobinsPolymersZincBlood PreservationChromatography, AffinityHemolysisHumansSpectrophotometry, UltravioletHemoglobinsPolymersZincBlood productsHbHemolysisRBCTransfusionZinc resin

Identifiers

PMID30919138
PMCPMC6506348

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.